What works for Whom in Pediatric OCD
什么对儿童强迫症患者有效
基本信息
- 批准号:10665713
- 负责人:
- 金额:$ 34.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-15 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAgeAppleBehavior TherapyCaregiversCharacteristicsChildChildhoodClinicalClinical DataClinical TrialsCognitiveCognitive TherapyDataDevelopmentDoseEducationEmotionalEvaluationEvidence based interventionFamilyFamily psychotherapyFoundationsHeadHospitalsIndividualInfrastructureInternationalInterventionLeadershipLengthMeasuresMeta-AnalysisMethodsModalityModificationNational Institute of Mental HealthObsessive-Compulsive DisorderOutcomeParticipantPatient advocacyPatient-Focused OutcomesPatientsPopulationPreventionPrincipal InvestigatorProcessRecording of previous eventsRelaxationResearchSample SizeSamplingScheduleSeveritiesSeverity of illnessStatistical ModelsSubgroupSymptomsTarget PopulationsTestingTimeTransportationTreatment EffectivenessTreatment EfficacyVariantWorkanalytical toolburden of illnesscomorbiditycomparative effectivenesscompare effectivenesscomparison interventiondata archiveethnic minority populationimprovedinsightmemberoutpatient programspatient subsetsprogramsracial minority populationrandomized trialreduce symptomsresponsesocialtherapy outcometreatment comparisontreatment responseusability
项目摘要
Project Summary/Abstract
Improving patient outcomes will be enhanced by understanding “what works, for whom?” enabling better
matching of patients to available treatments. Despite a wealth of research seeking to optimize CBT outcomes
for pediatric obsessive-compulsive disorder (OCD), we have limited understanding about how to match
patients with the appropriate treatment package. Past research has identified patient characteristics that may
influence treatment response, including age, symptom severity, comorbidities, and previous treatment history.
Unfortunately, findings have been inconsistent due to limited sample size, a focus on one modifier at a
time, and difficulty integrating results across trials with different sample characteristics. Between-trial
differences in sample characteristics severely limit conventional meta-analytic tools, greatly complicating
cross-trial comparisons of treatment efficacy. This project will use individual-participant-data from 27 trials and
data from two clinical populations and utilize recent advancements in transportability methods facilitates
understanding “what works, for whom?” Transportability methods include causal analytic approaches to
extend inferences from trial samples to target populations when there are marked differences in the distribution
of sample characteristics between trials and the target population. Robust statistical models are used
to address between-trial differences in covariates, enabling the transportation of causal estimates from trial
samples to target populations. Under explicit causal and statistical assumptions, the transported analyses
provide unbiased estimates of how interventions will fair in the target population(s), enabling apples-to-apples
comparisons of interventions even when two interventions have not been compared in a head-to-head trial. In
addition, the target population can be defined as sub-populations (e.g., younger children with high illness
severity, comorbidities), enabling evaluation of relevant interventions for that sub-population, effectively
providing insight into the question of “what works for whom?”
项目摘要/摘要
通过理解“什么是有效的,对谁有效?”可以改善患者的预后。实现更好的
将患者与可用的治疗相匹配。尽管有大量研究寻求优化CBT结果
对于儿童强迫症(OCD),我们对如何匹配的了解有限
为患者提供适当的治疗方案。过去的研究已经确定了患者的特征,可能
影响治疗反应,包括年龄、症状严重程度、合并症和既往治疗史。
不幸的是,由于样本量有限,结果一直不一致,只关注一种修饰物
时间长,难以整合不同样本特性的试验结果。审判间歇
样品特性的差异严重限制了传统的元分析工具,极大地复杂化了
治疗效果的交叉试验比较。该项目将使用来自27个试验的个人参与者数据和
来自两个临床人群的数据,并利用可携带性方法的最新进展,有助于
理解“什么对谁管用?”可运输性方法包括因果分析方法
当分布有显著差异时,将推论从试验样本扩展到目标人群
试验和目标人群之间的样本特征。使用稳健的统计模型
处理试验间协变量的差异,使试验中的因果估计得以传递
将样本转移到目标人群。在明确的因果和统计假设下,传输的分析
对干预措施在目标人群中的公平性提供公正的估计(S),使双方能够平分秋色
干预措施的比较,即使在两种干预措施没有在面对面试验中进行比较的情况下也是如此。在……里面
此外,目标人群可以被定义为亚人群(例如,患有高疾病的较小儿童
严重性、合并症),从而能够有效地评估针对该亚人群的相关干预措施
提供对“什么对谁有效?”这一问题的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID Heaton BARKER其他文献
DAVID Heaton BARKER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID Heaton BARKER', 18)}}的其他基金
Comparative Efficacy of HIV-Prevention among Youth with Mental Health Needs
有心理健康需求的青少年艾滋病毒预防的比较效果
- 批准号:
9026651 - 财政年份:2014
- 资助金额:
$ 34.69万 - 项目类别:
Comparative Efficacy of HIV-Prevention among Youth with Mental Health Needs
有心理健康需求的青少年艾滋病毒预防的比较效果
- 批准号:
8727174 - 财政年份:2014
- 资助金额:
$ 34.69万 - 项目类别:
Comparative Efficacy of HIV-Prevention among Youth with Mental Health Needs
有心理健康需求的青少年艾滋病毒预防的比较效果
- 批准号:
8848142 - 财政年份:2014
- 资助金额:
$ 34.69万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 34.69万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 34.69万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 34.69万 - 项目类别:
Fellowship
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 34.69万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 34.69万 - 项目类别:
Continuing Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 34.69万 - 项目类别:
Standard Grant
The economics of (mis)information in the age of social media
社交媒体时代(错误)信息的经济学
- 批准号:
DP240103257 - 财政年份:2024
- 资助金额:
$ 34.69万 - 项目类别:
Discovery Projects
How age & sex impact the transcriptional control of mammalian muscle growth
你多大
- 批准号:
DP240100408 - 财政年份:2024
- 资助金额:
$ 34.69万 - 项目类别:
Discovery Projects
Supporting teachers and teaching in the age of Artificial Intelligence
支持人工智能时代的教师和教学
- 批准号:
DP240100111 - 财政年份:2024
- 资助金额:
$ 34.69万 - 项目类别:
Discovery Projects
Enhancing Wahkohtowin (Kinship beyond the immediate family) Community-based models of care to reach and support Indigenous and racialized women of reproductive age and pregnant women in Canada for the prevention of congenital syphilis
加强 Wahkohtowin(直系亲属以外的亲属关系)以社区为基础的护理模式,以接触和支持加拿大的土著和种族育龄妇女以及孕妇,预防先天梅毒
- 批准号:
502786 - 财政年份:2024
- 资助金额:
$ 34.69万 - 项目类别:
Directed Grant














{{item.name}}会员




